Amemiya K, Hurley L S, Keen C L
Department of Nutrition, University of California, Davis 95616.
Teratology. 1989 Apr;39(4):387-93. doi: 10.1002/tera.1420390410.
The effect of 6-mercaptopurine (6-MP) on the distribution of gavaged 65Zn in maternal and embryonic tissues of Sprague-Dawley rats was examined 24 hr after injection of the drug on day 13 of pregnancy. 6-MP injection resulted in a significantly higher retention of counts of 65Zn in maternal liver and lower counts in maternal plasma, uterus, placenta, and embryo than in controls. Compared to controls, gel chromatography of maternal liver from 6-MP injected dams showed higher counts associated with a protein peak of molecular weight 6,000-8,000, the approximate molecular weight of the zinc-binding protein metallothionein. These results support the idea that the zinc deficiency, which is observed in day 21 fetuses from dams injected with 6-MP during midgestation, may be the result of a drug-induced sequestering of zinc into maternal liver followed by a decrease in maternal plasma zinc and subsequent reduction in fetal zinc uptake. We suggest that this 6-MP-associated redistribution of zinc into maternal liver may be due to induction of maternal metallothionein synthesis by the drug.
在妊娠第13天注射6-巯基嘌呤(6-MP)24小时后,研究了其对灌胃给予的65Zn在斯普拉格-道利大鼠母体和胚胎组织中分布的影响。注射6-MP后,母体肝脏中65Zn的计数保留显著高于对照组,而母体血浆、子宫、胎盘和胚胎中的计数低于对照组。与对照组相比,对注射6-MP的母鼠的肝脏进行凝胶色谱分析显示,与分子量为6000 - 8000的蛋白质峰相关的计数更高,这一分子量近似于锌结合蛋白金属硫蛋白的分子量。这些结果支持了这样一种观点,即在妊娠中期注射6-MP的母鼠所产的21日龄胎儿中观察到的锌缺乏,可能是药物诱导锌螯合到母体肝脏中,随后母体血浆锌减少,进而胎儿锌摄取减少的结果。我们认为,这种与6-MP相关的锌重新分布到母体肝脏中,可能是由于该药物诱导母体金属硫蛋白合成所致。